X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

HRMY

Closed

Harmony Biosciences Holdings

32.03
+0.43 (+1.36%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 31.6
Day's Range: 31.82 - 33.69
Send
When Written:
 
33.03
Harmony Biosciences Holdings, Inc. is a biopharmaceutical company based in Plymouth Meeting, Pennsylvania. The company is focused on developing and commercializing innovative therapies for people living with rare neurological disorders. Harmony's first product, WAKIX® (pitolisant), was approved by the U.S. Food and Drug Administration (FDA) in 2019 for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy. The company is also developing a pipeline of novel therapies for other rare neurological conditions, including idiopathic hypersomnia, REM sleep behavior disorder, and narcolepsy in pediatric patients. Harmony Biosciences Holdings, Inc. was founded in 2017 and went public in 2020.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X